Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on establishing the European Competitiveness Fund ('ECF’), including the specific programme for defence research and innovation activities, repealing Regulations (EU) 2021/522, (EU) 2021/694, (EU) 2021/697, (EU) 2021/783, repealing provisions of Regulations (EU) 2021/696, (EU) 2023/588, and amending Regulation (EU) [EDIP]

12 Nov 2025

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing Horizon Europe, the Framework Programme for Research and Innovation, for the period 2028-2034 laying down its rules for participation and dissemination, and repealing Regulation (EU) 2021/695

7 Nov 2025

Response to Regulation of the European Parliament and of the Council establishing a framework of measures for strengthening Europe’s innovation ecosystem

2 Oct 2025

Meeting with Ekaterina Zaharieva (Commissioner) and 1 other attendee

19 Sept 2025 · Childhood cancer

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

4 Jul 2025

Meeting with Adam Jarubas (Member of the European Parliament, Committee chair)

30 Jun 2025 · Tackling Childhood Cancer: Cross Border Healthcare & Research

Meeting with Maya Matthews (Head of Unit Health and Food Safety)

20 Jun 2025 · Discussion on the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment.

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

6 Jun 2025

Meeting with Olivér Várhelyi (Commissioner) and 3 other attendees

28 May 2025 · Childhood cancer

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

15 Apr 2025

Meeting with Oliver Schenk (Member of the European Parliament)

26 Mar 2025 · Childhood Cancer

Response to Critical Medicines Act

27 Feb 2025

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament) and 2 other interest representatives

15 Jan 2025 · Intergroup on cancer and rare diseases

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament)

31 Oct 2024 · Introductory meeting

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

21 Oct 2024

Meeting with Kathleen Funchion (Member of the European Parliament)

1 Oct 2024 · Introductory Meeting

Meeting with Tilly Metz (Member of the European Parliament)

13 Sept 2024 · Cancer

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

24 Jul 2024

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament)

18 Jul 2024 · Introductory Meeting

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

28 Mar 2024

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

13 Feb 2024 · Pharmaceutical legislation

Response to Report on the application of the General Data Protection Regulation to the European Parliament and the Council

8 Feb 2024

Response to Interim evaluation of the EU4Health Programme Regulation (EU) No 2021/522 - Report to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the interim evaluation of the EU4Health Programme

9 Jan 2024

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

8 Nov 2023

Meeting with Deirdre Clune (Member of the European Parliament)

10 Oct 2023 · Cancer

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

18 Aug 2023 · Directive on Medicinal products for human use

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur)

9 Jun 2023 · Directive on Medicinal products for human use

Response to Ex-post evaluation of the Horizon 2020 framework programme for Research and Innovation

29 Jul 2022

Response to COMMISSION STAFF WORKING DOCUMENT - EVALUATION - Interim evaluation of the Horizon Europe framework programme for Research and Innovation

29 Jul 2022

Response to Commission Communication on a new European Innovation Agenda

10 May 2022

Response to Commission Communication on the European Care Strategy : strengthening long term care and early childhood education and care

29 Mar 2022

Meeting with Irena Joveva (Member of the European Parliament)

13 Sept 2021 · Paediatric oncology in the BECA report

Meeting with Stella Kyriakides (Commissioner) and 2 other interest representatives

18 May 2021 · Exchange of views on the implementation of Europe’s Beating Cancer Plan in paediatric oncology

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Report from the Commission to the EP and Council on the operation and performance of the Directive 2011/24/EU on the application of patient rights in cross-border healthcare foreseen under Article 17(1) and Article 20(1) & (2) of Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011

11 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

3 Feb 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to Commission communication on a comprehensive strategy on the rights of the child

5 Aug 2020

Meeting with Mariya Gabriel (Commissioner)

9 Jun 2020 · EU Paediatric Cancer Research agenda and how the European Paediatric Cancer Community could best partake in and support relevant initiatives

Meeting with Stella Kyriakides (Commissioner)

26 May 2020 · VC meeting to discuss the EU's Cancer Plan and its objectives, cancer care and treatment during the COVID-19 pandemic

Response to Commission Communication on Europe’s Beating Cancer Action Plan

3 Mar 2020

Meeting with Stella Kyriakides (Commissioner) and 1 other attendee

21 Jan 2020 · Discussion on cancer

Response to Proposal for a COUNCIL REGULATION for a European Partnership (Joint Undertaking) for innovative health

27 Aug 2019

Response to Commission Recommendation on the European Electronic Health Record (EHR) Exchange Format

19 Dec 2018

Meeting with Robert Schröder (Cabinet of Commissioner Carlos Moedas)

13 Dec 2018 · Health research and innovation

Response to Joint evaluation of Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products

8 Jan 2018

Meeting with Marika Lautso-Mousnier (Cabinet of Vice-President Jyrki Katainen)

19 Sept 2017 · Paediatric Regulation evaluation report

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

12 Jun 2017 · Paediatric medicines